TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23995437

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter defibrillator-CRT in patients with LBBB
Number of subjects: 1483

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter defibrillator-CRT in patients with non-LBBB and QRS ≥160 ms
Number of subjects: 1483

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter defibrillator-CRT in patients with non-LBBB and QRS <160 ms
Number of subjects: 1483
Study: 21304300

Group type: EXPERIMENTAL
Intervention: Sinus excision and primary closure
Number of subjects: 80

Group type: COMPARATOR
Intervention: Laying open
Number of subjects: 80
Study: 18086143

Group type: EXPERIMENTAL
Intervention: Mechanically polished (MP) acrylic resin
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Chemically polished (CP) acrylic resin
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Brushing with MFP dentifrice
Number of subjects: 80

Group type: COMPARATOR
Intervention: Brushing with Tartar Control dentifrice
Number of subjects: 80
Study: 17051978

Group type: EXPERIMENTAL
Intervention: Amino acid solution (A group)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Electrolyte solution (S group)
Number of subjects: 74
Study: 12626906

Group type: EXPERIMENTAL
Intervention: Carbon dioxide insufflation
Number of subjects: 247

Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 247
Study: 11093505

Group type: EXPERIMENTAL
Intervention: tThx (thoracoscopic thymectomy)
Number of subjects: 20

Group type: COMPARATOR
Intervention: sThx (median sternotomy)
Number of subjects: 20
Study: 8730075

Group type: EXPERIMENTAL
Intervention: Correlated multiband masker
Number of subjects: 3

Group type: COMPARATOR
Intervention: Single-band masker
Number of subjects: 3

Group type: COMPARATOR
Intervention: Uncorrelated multiband masker
Number of subjects: 3
Study: 1467605

Group type: EXPERIMENTAL
Intervention: Kangaroo method
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Traditional oil massage
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Plastic swaddler
Number of subjects: 300

Group type: COMPARATOR
Intervention: Observation study
Number of subjects: 300
Study: 29303025

Group type: EXPERIMENTAL
Intervention: Maternal 25(OH)D < 75 nmol/L during pregnancy
Number of subjects: 52

Group type: COMPARATOR
Intervention: Maternal 25(OH)D ≥ 75 nmol/L during pregnancy
Number of subjects: 52
Study: 29523173

Group type: EXPERIMENTAL
Intervention: Agricultural extension platform of women's groups viewing and discussing videos on nutrition-sensitive agriculture (NSA) practices, with follow-up visits.
Number of subjects: 1184

Group type: EXPERIMENTAL
Intervention: Women's groups viewing and discussing videos on NSA and nutrition-specific practices, with follow-up visits.
Number of subjects: 1184

Group type: EXPERIMENTAL
Intervention: Women's groups viewing and discussing videos on NSA and nutrition-specific practices combined with Participatory Learning and Action meetings, with follow-up visits.
Number of subjects: 1184

Group type: COMPARATOR
Intervention: Control group receiving basic nutrition training from government community frontline workers.
Number of subjects: 1184
Study: 26874269

Group type: EXPERIMENTAL
Intervention: AAT-training
Number of subjects: 139

Group type: COMPARATOR
Intervention: Sham-training
Number of subjects: 139
Study: 24888230

Group type: EXPERIMENTAL
Intervention: Ombrabulin 35 mg/m²
Number of subjects: 176

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 176
Study: 22257576

Group type: EXPERIMENTAL
Intervention: Estradiol‐Depot 10 mg® (test)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Progynon Depot‐10® (reference)
Number of subjects: 24
Study: 20003918

Group type: EXPERIMENTAL
Intervention: Live attenuated influenza vaccine (LAIV)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 17716800

Group type: EXPERIMENTAL
Intervention: Cast post-and-core restorations
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Prefabricated metal post and resin composite core restorations
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Post-free all-composite core restorations
Number of subjects: 257

Group type: COMPARATOR
Intervention: All types of post-and-core restorations
Number of subjects: 257
Study: 15168120

Group type: EXPERIMENTAL
Intervention: Multiple recall tests
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single long test of equal total duration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple recall tests with a brief delay (15 min)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single test condition
Number of subjects: 0
Study: 11911756

Group type: EXPERIMENTAL
Intervention: Milrinone (0.5 microg/kg per minute for 48 hours)
Number of subjects: 951

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 951

Group type: EXPERIMENTAL
Intervention: Milrinone
Number of subjects: 951
Study: 9805117

Group type: EXPERIMENTAL
Intervention: Iced injectate
Number of subjects: 50

Group type: COMPARATOR
Intervention: Room-temperature injectate
Number of subjects: 50
Study: 7621686

Group type: EXPERIMENTAL
Intervention: Mesigyna
Number of subjects: 5098

Group type: EXPERIMENTAL
Intervention: Cyclofem
Number of subjects: 5098

Group type: EXPERIMENTAL
Intervention: Injectable No. 1
Number of subjects: 5098

Group type: COMPARATOR
Intervention: Mesigyna vs Cyclofem
Number of subjects: 5098
Study: 2133202

Group type: EXPERIMENTAL
Intervention: Hand instruments
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Roto-pro instruments
Number of subjects: 50

Group type: COMPARATOR
Intervention: Both methods
Number of subjects: 50
Study: 378315

Group type: EXPERIMENTAL
Intervention: High vacuum Redivac drains
Number of subjects: 46

Group type: COMPARATOR
Intervention: Low vacuum Portovac drains
Number of subjects: 46
Study: 31190476

Group type: EXPERIMENTAL
Intervention: Bacillus Calmette‐Guérin vaccination
Number of subjects: 1241

Group type: EXPERIMENTAL
Intervention: Atopic dermatitis
Number of subjects: 1241

Group type: EXPERIMENTAL
Intervention: Overall sensitization
Number of subjects: 1241

Group type: EXPERIMENTAL
Intervention: Atopic dermatitis in sensitized children
Number of subjects: 1241
Study: 28968759

Group type: EXPERIMENTAL
Intervention: PENNVAX-G DNA delivered intramuscularly by Biojector
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: PENNVAX-G DNA delivered intramuscularly by CELLECTRA electroporation device
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: PENNVAX-G DNA followed by MVA-CMDR boost
Number of subjects: 100
Study: 25883095

Group type: EXPERIMENTAL
Intervention: Epidural steroid injection
Number of subjects: 145

Group type: COMPARATOR
Intervention: Gabapentin
Number of subjects: 145
Study: 23576032

Group type: EXPERIMENTAL
Intervention: Tailored post‐operative physiotherapy programme
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard physiotherapy
Number of subjects: 80
Study: 21286810

Group type: EXPERIMENTAL
Intervention: Click City®: Tobacco
Number of subjects: 47

Group type: COMPARATOR
Intervention: Usual curriculum
Number of subjects: 47
Study: 18986859

Group type: EXPERIMENTAL
Intervention: PRI 1
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: PRI 2
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Perlane
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Zyplast
Number of subjects: 79
Study: 17234439

Group type: EXPERIMENTAL
Intervention: Norepinephrine iontophoresis
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline iontophoresis
Number of subjects: 10

Group type: COMPARATOR
Intervention: Acetylsalicylic acid injection
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline injection
Number of subjects: 10
Study: 15509420

Group type: EXPERIMENTAL
Intervention: Chloroquine
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Quinine
Number of subjects: 96
Study: 11694687

Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 1109

Group type: COMPARATOR
Intervention: No epidural analgesia
Number of subjects: 1109
Study: 9134635

Group type: EXPERIMENTAL
Intervention: All-trans retinoic acid (ATRA)
Number of subjects: 16
Study: 7956552

Group type: EXPERIMENTAL
Intervention: MOM nutrient powder (30 g/day)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Iron, folic acid, calcium, vitA+D
Number of subjects: 90
Study: 2892349

Group type: EXPERIMENTAL
Intervention: Ritanserin, 10 mg b.i.d.
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 31988102

Group type: EXPERIMENTAL
Intervention: Linezolid 1,200 mg QD
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Linezolid 600 mg BD
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Linezolid 600 mg QD
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Linezolid 300 mg BD
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Linezolid 300 mg QD
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Linezolid 1,200 mg TIW
Number of subjects: 114

Group type: COMPARATOR
Intervention: Combination of isoniazid, rifampin, pyrazinamide, and ethambutol
Number of subjects: 114
Study: 29789278

Group type: EXPERIMENTAL
Intervention: E-learning program for 6 months
Number of subjects: 269
Study: 27903518

Group type: EXPERIMENTAL
Intervention: LOW PRO diet (0.7 g · kg‐1 · d‐1)
Number of subjects: 24

Group type: COMPARATOR
Intervention: HIGH PRO diet (1.5 g · kg‐1 · d‐1)
Number of subjects: 24
Study: 25612882

Group type: EXPERIMENTAL
Intervention: 30 g of raw flaxseed powder every day for 40 days
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no flaxseed intervention)
Number of subjects: 70
Study: 23419887

Group type: EXPERIMENTAL
Intervention: Adapted mindfulness-based stress reduction (MBSR)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Cognitive behavioral therapy (CBT)
Number of subjects: 105
Study: 20153132

Group type: EXPERIMENTAL
Intervention: Chronic Disease Self‐Management Programme (CDSMP)
Number of subjects: 317
Study: 19189601

Group type: EXPERIMENTAL
Intervention: Day-care ward
Number of subjects: 238

Group type: COMPARATOR
Intervention: Inpatient ward
Number of subjects: 238

Group type: EXPERIMENTAL
Intervention: Both settings
Number of subjects: 238
Study: 15666380

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IPC)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard recovery (STD)
Number of subjects: 62
Study: 12623805

Group type: EXPERIMENTAL
Intervention: 0.5% levofloxacin
Number of subjects: 423

Group type: COMPARATOR
Intervention: 0.3% ofloxacin
Number of subjects: 423
Study: 10585031

Group type: EXPERIMENTAL
Intervention: Skeletonized ITA graft
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pedicled ITA graft
Number of subjects: 40
Study: 8948268

Group type: EXPERIMENTAL
Intervention: L-thyroxine (100 micrograms/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 1766495

Group type: EXPERIMENTAL
Intervention: Cellulose acetate membrane (Duo‐Flux, Cordis‐Dow)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Polyacrylonitrile membrane (Filtral 12, Hospal)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hemophan (GFS 120 Plus, Gambro)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Polysulfone (F6, Fresenius)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cuprammonium (AM50‐BIO, Asahi)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Other membranes
Number of subjects: 10
Study: 7465620

Group type: EXPERIMENTAL
Intervention: Fluori‐Methane spray and static passive stretch
Number of subjects: 30

Group type: COMPARATOR
Intervention: Static passive stretch
Number of subjects: 30
Study: 30928279

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (E2) treatment for 1 week
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo treatment for 1 week
Number of subjects: 27
Study: 28097626

Group type: EXPERIMENTAL
Intervention: Peer mentors delivering a physical activity intervention
Number of subjects: 76
Study: 25935101

Group type: EXPERIMENTAL
Intervention: Eye-related acupoints (eye-points)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Non-eye-related acupoints (non-eye-points)
Number of subjects: 22
Study: 23851969

Group type: EXPERIMENTAL
Intervention: Computer-assisted surgery (CAS)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Conventional TKA
Number of subjects: 67
Study: 21383392

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 53

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 53
Study: 19429570

Group type: EXPERIMENTAL
Intervention: Exercise training (gym followed by telephone-monitored home-based exercise training)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 223
Study: 18201582

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination of telmisartan 40 mg + amlodipine 5 mg (T+A)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Amlodipine 5 mg monotherapy (A)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: T+A
Number of subjects: 210

Group type: COMPARATOR
Intervention: A
Number of subjects: 210
Study: 14504682

Group type: EXPERIMENTAL
Intervention: Sertraline (50-200 mg once daily)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 187
Study: 11115423

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo supplementation
Number of subjects: 140
Study: 9450174

Group type: EXPERIMENTAL
Intervention: Spleen ultrafiltrate (Prosplen)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 7840861

Group type: EXPERIMENTAL
Intervention: 5 mg tropisetron
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 25 mg tropisetron
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 3048759

Group type: EXPERIMENTAL
Intervention: Amodiaquine (1800 mg for 3 days)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine (1500 mg and 75 mg, respectively)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Amodiaquine plus sulfadoxine
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Amodiaquine plus sulfadoxine-pyrimethamine
Number of subjects: 50
Study: 31128268

Group type: EXPERIMENTAL
Intervention: Citalopram (CTP) adjunctive to methylphenidate (MPH)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo (PBO) adjunctive to methylphenidate (MPH)
Number of subjects: 49
Study: 29606549

Group type: EXPERIMENTAL
Intervention: Proximal crescentic osteotomy (PCO)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Rotational scarf osteotomy
Number of subjects: 57
Study: 28800778

Group type: EXPERIMENTAL
Intervention: Individualized PEEP values determined during a static pulmonary compliance (Cstat)‐directed PEEP titration procedure
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard lung‐protective ventilation with a PEEP of 6 cmH2O
Number of subjects: 40
Study: 26273612

Group type: EXPERIMENTAL
Intervention: Leukocyte- and platelet-rich fibrin (L-PRF)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control (no L-PRF)
Number of subjects: 26
Study: 24285128

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate hydration
Number of subjects: 142

Group type: COMPARATOR
Intervention: Physiological saline hydration
Number of subjects: 142
Study: 20835903

Group type: EXPERIMENTAL
Intervention: Adaptive servoventilation (ASV)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (rejection of ASV treatment or usage <50% of nights possible and/or <4 h/night; n = 59)
Number of subjects: 105
Study: 19033511

Group type: EXPERIMENTAL
Intervention: Surgical attire
Number of subjects: 24

Group type: COMPARATOR
Intervention: Antichemical protective gear
Number of subjects: 24
Study: 17157757

Group type: EXPERIMENTAL
Intervention: L-carnitine supplementation (3000 mg/day)
Number of subjects: 27
Study: 14596355

Group type: EXPERIMENTAL
Intervention: Educational intervention
Number of subjects: 272

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Educational intervention in depressed patients
Number of subjects: 272

Group type: COMPARATOR
Intervention: Control group in depressed patients
Number of subjects: 272
Study: 10947749

Group type: EXPERIMENTAL
Intervention: Spinal anaesthesia
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Lumbar epidural anaesthesia
Number of subjects: 45
Study: 9065092

Group type: EXPERIMENTAL
Intervention: BCG vaccine instillations (1 mg, annual scheme)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control group (10 patients without bladder cancer and without vaccine instillations)
Number of subjects: 13
Study: 1426667

Group type: EXPERIMENTAL
Intervention: Connaught BCG (ImmuCyst)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Doxorubicin (DOX)
Number of subjects: 114
Study: 3971650

Group type: EXPERIMENTAL
Intervention: Intravenous flecainide (2 mg/kg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31127500

Group type: EXPERIMENTAL
Intervention: Palbociclib (125 mg/day) administered 3 weeks on/1 week off
Number of subjects: 101
Study: 28513088

Group type: EXPERIMENTAL
Intervention: Total Skeletal Muscle Area (SMA)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Psoas Muscle Area (PA)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Psoas Surface Area (PLW)
Number of subjects: 150
Study: 25297455

Group type: EXPERIMENTAL
Intervention: Strong importance
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Weak importance
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Strong goal congruence
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Weak goal congruence
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Strong future expectation
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Weak future expectation
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Strong possibility
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Weak possibility
Number of subjects: 245
Study: 23394517

Group type: EXPERIMENTAL
Intervention: Flupirtine (200 mg p.o.)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Flupirtine (3-30 μM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20673559

Group type: EXPERIMENTAL
Intervention: Maintenance treatment
Number of subjects: 44

Group type: COMPARATOR
Intervention: Intermittent treatment
Number of subjects: 44
Study: 19140911

Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation (SCS) ON
Number of subjects: 8

Group type: COMPARATOR
Intervention: Spinal cord stimulation (SCS) OFF
Number of subjects: 8
Study: 17197840

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine infusion (1.5 mg/kg bolus at induction, 2 mg/kg/h intraoperatively, 1.33 mg/kg/h for 24 h postoperatively)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intravenous lidocaine infusion
Number of subjects: 40
Study: 15249756

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (500 microg/puff, 2 puffs every 12 h; n=27)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo (n=26)
Number of subjects: 53
Study: 11581118

Group type: EXPERIMENTAL
Intervention: Tyrosine-free amino acid mixture
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control mixture
Number of subjects: 36
Study: 9727072

Group type: EXPERIMENTAL
Intervention: Oral estrogen (Premarin 1.25 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Transdermal estrogen (Estraderm 100TTS)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both oral and transdermal estrogen
Number of subjects: 18
Study: 7953225

Group type: EXPERIMENTAL
Intervention: Lunar DPX
Number of subjects: 24

Group type: COMPARATOR
Intervention: Hologic QDR
Number of subjects: 24
Study: 3135880

Group type: EXPERIMENTAL
Intervention: Conformable catheter
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control catheter
Number of subjects: 52
Study: 30235496

Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 112

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 112
Study: 28638000

Group type: EXPERIMENTAL
Intervention: Supervised exercise group (SG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Voluntary exercise group (VG)
Number of subjects: 30
Study: 26088605

Group type: EXPERIMENTAL
Intervention: Computerized patient decision aid (P-DA) with usual care
Number of subjects: 74

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 74
Study: 23280269

Group type: EXPERIMENTAL
Intervention: Robotic-assisted home therapy
Number of subjects: 96

Group type: COMPARATOR
Intervention: Home exercise program
Number of subjects: 96
Study: 22127691

Group type: EXPERIMENTAL
Intervention: Rituximab treatment
Number of subjects: 1008
Study: 18166173

Group type: EXPERIMENTAL
Intervention: Perifollicular vascularity assessment using power Doppler ultrasonography
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard morphologic criteria
Number of subjects: 60
Study: 17065108

Group type: EXPERIMENTAL
Intervention: Dipyridamole 400 mg/day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 12579266

Group type: EXPERIMENTAL
Intervention: Skp2 overexpression
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Skp2 overexpression and reduced p27kip1 expression
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Skp2 expression in early stage (I, II) cases
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Skp2 expression, tumor grade, tumor size, clinical stage
Number of subjects: 102
Study: 10868722

Group type: EXPERIMENTAL
Intervention: Frontal Lobe Score
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Wisconsin Card Sorting Test (WCST)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Stroop Test
Number of subjects: 108
Study: 9291301

Group type: EXPERIMENTAL
Intervention: Serotype G1 monovalent vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serotype G1‐G4 tetravalent vaccine
Number of subjects: 0
Study: 8349389

Group type: EXPERIMENTAL
Intervention: Comprehensive program of smoking control, discouragement, and cessation
Number of subjects: 3

Group type: COMPARATOR
Intervention: Smoking cessation only
Number of subjects: 3
Study: 3792434

Group type: EXPERIMENTAL
Intervention: Ciramadol 15 mg
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Ciramadol 30 mg
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Ciramadol 60 mg
Number of subjects: 79

Group type: COMPARATOR
Intervention: Codeine 60 mg
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79